language_icon
EN
HI

Invicta Diagnostic Share price

INVICTA

86.1

0.00 (0.00%)
Last updated on 13 May, 2026 | 09:00 IST
Today's High

00

Today's Low

00

52 Week Low

58.10

52 Week High

105.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Invicta Diagnostic Chart

Invicta Diagnostic Share Key Metrics

Volume
0.00
Market Cap
108.24 CR
LTQ@LTP
1600@86.10
ATP
0
Var Margin
100 %
Circuit Range
81.8-90.4
Delivery %
83.33 %
Value
0.00
ASM/GSM
No
Market Lot
1600

Summary

13 May, 2026 | 09:00 को, Invicta Diagnostic का शेयर प्राइस आज ₹86.1 पर है, जो दिन के लिए 0.00% की 0.00 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹00 और ₹00 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹58.10 से ₹105.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Invicta Diagnostic ने शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹12571973 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹ है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 1600,8610 रही। यह स्टॉक ₹81.8-90.4 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹0.00 है। दिन के लिए डिलीवरी परसेंटेज 83.33% रही। इसके अतिरिक्त, Invicta Diagnostic वर्तमान में No फ्रेमवर्क के तहत आता है और 1600 के मार्केट लॉट साइज़ में ट्रेड करता

Invicta Diagnostic Fundamentals

View More
P/E Ratio

22.13

P/B Ratio

5.76

Div. Yield

0

Sector P/E

55.61

Sector P/B

-15.8

Sec. Div. Yield

1.93

Invicta Diagnostic Resistance and Support

Pivot 86.73

Resistance

First Resistance

87.36

Second Resistance

88.63

Third Resistance

89.26

Support

First Support

85.46

Second Support

84.83

Third Support

83.56

Invicta Diagnostic Shareholding Pattern

View More
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

66.7%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

4.2%

Domestic Institutional Investors

4.3%

Retail

24.81%

Others

-0.01%

Total Promoters
MAR '26
66.7%

Invicta Diagnostic Corporate Actions

DateAgenda
No Data Found

Invicta Diagnostic News

Invicta Diagnostic Limited

Invicta Diagnostic Limited's Board of Directors will hold a meeting on May 18, 2026. The primary agenda is to consider and approve the audited standalone and consolidated yearly financial results for the period ended March 2026.
May 13 2026 20:05:00

Invicta Diagnostic Limited

Invicta Diagnostic's board will convene on May 18, 2026, to consider and approve the standalone and consolidated audited financial results for the fiscal year ended March 31, 2026. This meeting is a routine announcement for annual financial disclosures.
May 13 2026 20:05:00

Invicta Diagnostic Limited

Invicta Diagnostic has completed the acquisition of a 51% stake in Vinchurkar Diagnostics Private Limited. This is the first tranche of a proposed 95% acquisition, with the total cash consideration for 95% being Rs. 7.60 crores.
May 08 2026 20:05:00

Invicta Diagnostic Limited

Invicta Diagnostic Limited has completed the acquisition of a 51% majority stake in Vinchurkar Diagnostics Private Limited. This strategic move strengthens the company's presence in the diagnostics sector.
May 08 2026 19:05:00

Invicta Diagnostic Limited (INVICTA)

Invicta Diagnostic held an EGM on April 17, 2026, where all 16 resolutions were approved. Key items included the regularization of Director Rohit Prakash Srivastava and various related party transactions.
Apr 18 2026 18:04:00

Invicta Diagnostic Limited (INVICTA)

Invicta Diagnostic announced Rohit Prakash Srivastava's redesignation to Whole Time Director Finance. This formalizes his key leadership role for a five-year term, effective April 17, 2026, leveraging his 19 years of experience.
Apr 17 2026 21:04:00

Invicta Diagnostic Limited (INVICTA)

Invicta Diagnostic's EGM on April 17, 2026, approved 15 material related party transactions and changes to IPO proceeds utilization and extension of time limit. This includes regularizing Mr. Rohit Prakash Srivastava as Whole-Time Director (Finance) for a 5-year tenure with ₹7.20 Lakh annual remuneration.
Apr 17 2026 20:04:00
Read More

About Invicta Diagnostic AboutThe

NSE : 760142  
BSE : 0  
ISIN : INE0XJ501010  

Our Company was incorporated as Limited Liability Partnership under the name “Invicta Diagnostic LLP” under the provisions of the Limited Liability Partnership Act 2008 vide Certificate of Incorporation dated January 22 2021 issued by Assistant Registrar of Companies Central Registration Centre. Further Invicta Diagnostic LLP was converted into a private limited company “Invicta Diagnostic Private Limited” pursuant to the provisions of Chapter XXI of the Companies Act 2013 and a fresh Certificate of Incorporation dated December 01 2023 was issued by Assistant Registrar of Companies Central Registration Centre. Subsequently our Company was converted from a private limited company to a public limited company pursuant to a resolution passed in the extraordinary general meeting of our Shareholders held on April 20 2024 and the name of our Company was changed to “Invicta Diagnostic Limited” and a fresh certificate of incorporation dated July 02 2024 was issued to our Company by the Assistant Registrar of Companies/ Deputy Registrar of Companies/ Registrar of Companies Central Processing Centre. The Corporate Identification Number of our Company is U86100MH2023PLC414723.Major Events and Milestones:2021- Incorporation of Erstwhile LLP- Setting up of 1st fully integrated Diagnostic Centre in Thane having the entire gamut of services under its umbrella including PET CT scans CT scans MRI Scans Sonography X-Ray and Pathology2023- Conversion of Erstwhile LLP into a private limited company “Invicta Diagnostic Private Limited” pursuant to the provisions of Chapter XXI of the Companies Act 2013- Acquisition of majority shareholding in “PCD Diagnostics LLP” for a full-fledged diagnostic centre in Marol Andheri East forming it our subsidiary- Acquisition of majority shareholding in “Primacare Healthcare LLP” for a full-fledged diagnostic centre in Byculla forming it our subsidiary- Acquisition of majority shareholding in “Pratham MRI and CT Scan Centre” for a full-fledged diagnostic centre in Bhayandar forming it our subsidiary2024- Acquisition of a diagnostic centre in Sewri from PCD Medical LLP- Acquisition of a diagnostic centre in Parel from Primacare Diagnostic LLP- Acquisition of a centralised laboratory in Parel from Porteus Path Lab LLP- Formation of our subsidiary “Invicta Medical LLP” for setting up of diagnostic centre in KalwaThane- Conversion from Private Limited to Public Limited Company2025- Acquisition of “Porteus Medical LLP” (Formerly known as “Porteus Porteus Path Lab LLP”) for forming it our subsidiary- Acquisition of “Primacare Diagnostic LLP” for setting up of diagnostic centre in Dadar Mumbai forming it our subsidiary- Acquisition of “MSCRIBEIT Infotech LLP” (Formerly Knowns as “PCD Medical LLP”) forming it our Associate

Read More

Invicta Diagnostic Management

NamePosition
Ketan Jayantilal JainNon Executive Director
Sanket Vinod JainChairman
View More

Invicta Diagnostic FAQs

Invicta Diagnostic शेयर का खरीद मूल्य 86.1 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Invicta Diagnostic शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Invicta Diagnostic शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 22.13 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Invicta Diagnostic शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 5.76 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Invicta Diagnostic शेयर का प्राइस-टू-बुक (पी/बी) रेशियो -15.8 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Invicta Diagnostic का मार्केट कैप 108.24 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Invicta Diagnostic शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 105.00 और 58.10 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost